ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings
Filings indexed
1,039
across all filing types
Latest filing
2026-05-07
Regulatory Filings
Country
US
United States of America
Listing
US
ARWR
Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | |
| 10-Q | 2026-05-07 | English | |
| 8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-06 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| Major Shareholding Notification 2026 | 2026-04-28 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 43600570 | S-8 - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | ||
| 46149826 | 10-Q | 2026-05-07 | English | ||
| 43480488 | 8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | ||
| 46149831 | Major Shareholding Notification 2026 | 2026-05-06 | English | ||
| 46149840 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 46149844 | Major Shareholding Notification 2026 | 2026-04-28 | English | ||
| 46149849 | Major Shareholding Notification 2026 | 2026-04-24 | English | ||
| 33051854 | SCHEDULE 13G/A - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Subject) | 2026-03-26 | English | ||
| 46149856 | 8-K | 2026-03-20 | English | ||
| 32882864 | 10-Q - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-02-05 | English | ||
| 24687705 | 8-K Filing | 2026-02-05 | English | ||
| 24687727 | DEF 14A Filing | 2026-01-27 | English | ||
| 32882862 | ARS - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-01-27 | English | ||
| 46149866 | DEFA14A | 2026-01-26 | English | ||
| 24687718 | 8-K Filing | 2026-01-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
|
BIOSIS GROUP BERHAD
Manufacturer of pharmaceutical, personal care, skincare, an…
|
— | MY | Manufacturing |
|
Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-labor…
|
086820 | KR | Manufacturing |
|
BioSyent Inc.
Specialty pharmaceutical company developing and commerciali…
|
RX | CA | Manufacturing |
|
Biosynex
Designs and distributes medical diagnostic solutions, inclu…
|
ALBIO | FR | Manufacturing |
ARROWHEAD PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31071/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31071 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31071 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31071 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31071}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARROWHEAD PHARMACEUTICALS, INC. (id: 31071)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.